Contraindicated. Coadministration of doravirine with a robust CYP3A inducer might minimize doravirine plasma concentrations and/or effects. Potential for loss of virologic response and feasible resistance to doravirine.pentobarbital will lessen the extent or outcome of meloxicam by affecting hepatic enzyme CYP2C9/ten metabolism. Minor/Significance